Mounjaro 15 mg
Mounjaro (tirzepatide) is a once-weekly subcutaneous injectable medication used to improve blood sugar control in adults with type 2 diabetes and for weight management. It works as a dual GIP and GLP-1 receptor agonist to reduce appetite and enhance insulin secretion. It is available in six strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. Treatment typically begins at 2.5 mg and is gradually escalated every 4 weeks under medical supervision.
18,150 ج.م
● In Stock